EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 95 filers reported holding EPIZYME INC in Q2 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $290,000 | -96.9% | 15,100 | -97.0% | 0.02% | -97.0% |
| Q4 2014 | $9,360,000 | +27.9% | 496,000 | +83.8% | 0.50% | +14.5% |
| Q3 2014 | $7,317,000 | -16.1% | 269,882 | -3.7% | 0.43% | -11.8% |
| Q2 2014 | $8,719,000 | +36.4% | 280,182 | -0.2% | 0.49% | +37.0% |
| Q1 2014 | $6,393,000 | +126.0% | 280,752 | +179.2% | 0.36% | +107.5% |
| Q2 2013 | $2,829,000 | – | 100,569 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |